Cardinal Health, Inc. (NYSE: CAH) is a Healthcare company in the Medical - Distribution industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 36.04 | EPS (ttm) | 6.56 | Insider Own | 1.08% | Shs Outstand | 234.21M | Perf Week | 2.77% |
| Market Cap | 55.37B | Forward P/E | 17.40 | EPS next Y | 13.59 | Insider Trans | -0.20% | Shs Float | 233.73M | Perf Month | 1.13% |
| Enterprise Value | 60.35B | PEG | 17.82 | EPS next Q | - | Inst Own | - | Short Float | 2.89% | Perf Quarter | 27.59% |
| Income | 1.56B | P/S | 0.22 | EPS this Y | 84.65% | Inst Trans | - | Short Ratio | 2.85 | Perf Half Y | 4.06% |
| Sales | 250.50B | P/B | - | EPS next Y | 12.50% | ROA | 2.75% | Short Interest | 6.75M | Perf YTD | 15.04% |
| Book/sh | - | P/C | 11.09 | EPS next 5Y | 13.62% | ROE | -55.72% | 52W High | 244.78 -3.46% | Perf Year | 50.96% |
| Cash/sh | - | P/FCF | 12.61 | EPS past 3/5Y | - | ROIC | 11.62% | 52W Low | 137.70 71.62% | Perf 3Y | 153.95% |
| Dividend Est. | 2.06 (0.87%) | EV/EBITDA | 19.94 | Sales past 3/5Y | 7.07% 7.80% | Gross Margin | 3.68% | Volatility | 2.52% 2.17% | Perf 5Y | 298.11% |
| Dividend TTM | 2.05 (0.87%) | EV/Sales | 0.24 | EPS Y/Y TTM | 89.57% | Oper. Margin | 0.92% | ATR (14) | 5.52 | Perf 10Y | 186.34% |
| Dividend Ex-Date | Jul 01, 2026 | Quick Ratio | 0.48 | Sales Y/Y TTM | 10.46% | Profit Margin | 0.62% | RSI (14) | 57.96 | Recom | 2.45 |
| Dividend Gr. 3/5Y | 0.91% 0.95% | Current Ratio | 0.91 | EPS Q/Q | 64.25% | SMA20 | 2.70% | Beta | 0.52 | Target Price | 258.50 |
| Payout | 31.49% | Debt/Eq | - | Sales Q/Q | 11.05% | SMA50 | 4.92% | Rel Volume | 0.66 | Prev Close | 236.40 |
| Employees | 57,700 | LT Debt/Eq | -3.28 | Earnings | Aug 11 | SMA200 | 12.19% | Avg Volume | 2.34M | Price | 236.31 |
| IPO Date | Aug 04, 1983 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 13.43% -1.87% | Net Debt/EBITDA | 1.65 | Volume | 1,546,255 | Change | -0.04% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-20-26 | Reiterated | UBS | Buy | $260 → $274 |
| May-01-26 | Reiterated | Robert W. Baird | $257 → $248 | |
| Apr-08-26 | Reiterated | Evercore ISI Group | Outperform | $260 → $240 |
| Mar-09-26 | Reiterated | Leerink Partners | Outperform | $240 → $275 |
| Feb-24-26 | Reiterated | Barclays | Overweight | $243 → $258 |
| Feb-10-26 | Reiterated | Wells Fargo | Overweight | $179 → $256 |
| Feb-06-26 | Reiterated | Morgan Stanley | Overweight | $245 → $255 |
| Feb-06-26 | Reiterated | Robert W. Baird | $250 → $252 | |
| Feb-06-26 | Reiterated | UBS | Buy | $250 → $260 |
| Feb-06-26 | Reiterated | Mizuho | Outperform | $222 → $235 |
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 6/30/2025 | FY 2024 6/30/2024 | FY 2023 6/30/2023 | FY 2022 6/30/2022 | FY 2021 6/30/2021 | FY 2020 6/30/2020 | FY 2019 6/30/2019 | FY 2018 6/30/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 250,549 | 222,578 | 226,827 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 241,319 | 214,410 | 219,413 | — | — | — | — | — | — | |
| Gross Profit | 9,230 | 8,168 | 7,414 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 5,991 | 5,382 | 5,000 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 927 | 511 | 1,171 | — | — | — | — | — | — | |
| Operating Income | 2,312 | 2,275 | 1,243 | — | — | — | — | — | — | |
| Interest Expense | 343 | 215 | 51 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 35 | 41 | 9 | — | — | — | — | — | — | |
| Net Income Before Taxes | 2,004 | 2,101 | 1,201 | — | — | — | — | — | — | |
| Income Taxes | 456 | 532 | 348 | — | — | — | — | — | — | |
| Consolidated Net Income | 1,559 | 1,561 | 852 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,548 | 1,569 | 853 | — | — | — | — | — | — | |
| Net Income | 1,559 | 1,561 | 852 | — | — | — | — | — | — | |
| EPS (Recurring) | 6.56 | 6.48 | 3.48 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 6.56 | 6.48 | 3.48 | — | — | — | — | — | — | |
| EPS (Diluted) | 6.54 | 6.45 | 3.45 | — | — | — | — | — | — | |
| EBITDA | 3,026 | 3,106 | 1,962 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 36.13 | 26.05 | 28.50 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.22 | 0.18 | 0.11 | — | — | — | — | — | — | |
| Gross Margin | 3.68 | 3.67 | 3.27 | — | — | — | — | — | — | |
| Operating Margin | 0.92 | 1.02 | 0.55 | — | — | — | — | — | — | |
| Net Margin | 0.62 | 0.70 | 0.38 | — | — | — | — | — | — | |
| Shares Outstanding | 235 | 241 | 245 | — | — | — | — | — | — | |
| Market Capitalization | 55,534 | 40,488 | 24,088 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Greene Michelle D. | Chief Information Officer | Feb 27 '26 | Sale | 228.47 | 2,746 | 627,387 | 12,230 | Mar 03 |
| Alt Aaron E | Chief Financial Officer | Feb 18 '26 | Sale | 225.50 | 2,328 | 524,964 | 26,408 | Feb 18 |
| Hall Patricia Hemingway | Director | Feb 06 '26 | Sale | 229.72 | 4,000 | 918,880 | 28,264 | Feb 10 |
| WEITZMAN DEBORAH | CEO, PSS Segment | Aug 20 '25 | Sale | 150.53 | 21,367 | 3,216,375 | 53,428 | Aug 20 |
| Hollar Jason M. | Chief Executive Officer | Aug 20 '25 | Sale | 150.04 | 35,901 | 5,386,567 | 200,000 | Aug 20 |
| Hollar Jason M. | Chief Executive Officer | Aug 19 '25 | Sale | 148.90 | 107,705 | 16,037,649 | 235,901 | Aug 19 |
| Snow Ola M | Chief Human Resources Officer | Aug 19 '25 | Sale | 148.94 | 28,151 | 4,192,917 | 15,431 | Aug 19 |
| Scherer Mary C. | Chief Accounting Officer | Aug 19 '25 | Sale | 149.25 | 6,766 | 1,009,826 | 3,556 | Aug 19 |
| Alt Aaron E | Chief Financial Officer | Aug 19 '25 | Sale | 148.78 | 48,243 | 7,177,390 | 30,650 | Aug 19 |
| Greene Michelle D. | Chief Information Officer | Aug 19 '25 | Sale | 148.82 | 13,500 | 2,009,043 | 14,976 | Aug 19 |
| Mayer Jessica L | Chief Legal/Compliance Officer | Aug 19 '25 | Sale | 148.82 | 38,078 | 5,666,833 | 48,457 | Aug 19 |
| Mason Stephen M | CEO, GMPD Segment | Aug 19 '25 | Sale | 148.82 | 41,575 | 6,187,063 | 26,085 | Aug 19 |
| Scherer Mary C. | Chief Accounting Officer | Nov 14 '24 | Sale | 123.55 | 3,504 | 432,919 | 8,752 | Nov 14 |
| Mayer Jessica L | Chief Legal/Compliance Officer | Aug 21 '24 | Sale | 109.39 | 16,573 | 1,812,920 | 75,971 | Aug 22 |
| Greene Michelle D. | Chief Information Officer | Aug 19 '24 | Sale | 108.85 | 4,000 | 435,400 | 19,242 | Aug 19 |